New brain cancer therapy tested in groundbreaking trial
Disease control
Ongoing
This early-stage study is testing a new type of personalized cell therapy called CHM-1101 for adults with a specific type of aggressive brain cancer (glioblastoma) that has returned or gotten worse. Doctors will give the treatment directly into the brain to see if it is safe, fin…
Phase: PHASE1 • Sponsor: Chimeric Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC